Current Issue

Application of Quality Risk Management to Process Validation

Robert Dream, Managing Director, HDR Company LLC

A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization

Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...

Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...

Ping Wang, Director, Johnson & Johnson

Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics

Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...

Amsphere A3

JSR Life Sciences



Headline News

Teva discontinues Phase II emrusolmin trial in multiple system atrophy after futility analysis


Shockwave Javelin IVL catheter shows positive results in pivotal FORWARD CAD study


Impella registry analyses report lower mortality than CHIP-BCIS3 in high-risk PCI


Read All Headlines

Upcoming Webinars

View All Upcoming Webinars

Past Webinars

PDA Technical Report on Low Endotoxin Recovery: Implications to the Industry

Presented by Dr Friedrich von Wintzingerode, Senior Manager, Global Analytical Science & Technology (gASAT) Microbiology, Global QC bei Roche
03rd May 2019


Manufacturing strategies for Biosimilars: A case of continuous capture

Presented by Solomon Alva, Antibody Purification Group Lead, Senior Scientific Manager, Biocon Research Limited
15th June 2018


ICH Q3E Guidelines and Its Implications

Presented by Jason Creasey, Managing Director at Maven E&L Ltd and Dries Cardoen, Team Leader of Study Directors Inhalation/topical/transdermal products at Nelson Laboratories, LLC
22nd March 2021


View All Past Webinars

Featured Companies

 

View All Companies

© 2026 biopharma-asia.com. All rights reserved. Privacy Policy

Biopharma Asia